Cargando…
Medium-Chain Fatty Acids, Beta-Hydroxybutyric Acid and Genetic Modulation of the Carnitine Shuttle Are Protective in a Drosophila Model of ALS Based on TDP-43
ALS patients exhibit dyslipidemia, hypermetabolism and weight loss; in addition, cellular energetics deficits have been detected prior to denervation. Although evidence that metabolism is altered in ALS is compelling, the mechanisms underlying metabolic dysregulation and the contribution of altered...
Autores principales: | Manzo, Ernesto, O'Conner, Abigail G., Barrows, Jordan M., Shreiner, Dakotah D., Birchak, Gabriel J., Zarnescu, Daniela C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990617/ https://www.ncbi.nlm.nih.gov/pubmed/29904341 http://dx.doi.org/10.3389/fnmol.2018.00182 |
Ejemplares similares
-
Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS
por: Manzo, Ernesto, et al.
Publicado: (2019) -
TDP-43 Proteinopathy Causes Broad Metabolic Alterations including TCA Cycle Intermediates and Dopamine Levels in Drosophila Models of ALS
por: Loganathan, Suvithanandhini, et al.
Publicado: (2022) -
Endocytosis regulates TDP-43 toxicity and turnover
por: Liu, Guangbo, et al.
Publicado: (2017) -
Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle
por: Knottnerus, Suzan J. G., et al.
Publicado: (2018) -
To Be or Not To Be…Toxic—Is RNA Association With TDP-43 Complexes Deleterious or Protective in Neurodegeneration?
por: Loganathan, Suvithanandhini, et al.
Publicado: (2020)